Guardant Health, Inc.
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for…
Medical - Diagnostics & Research
US, Redwood City [HQ]
Ratios
8 Sheets · Starting from 2023Margins, Growth Rates In %
| Ratio | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|
| Profitability | |||||||||
| Gross Margin | 12.38 | 36.56 | 52.33 | 67.01 | 67.73 | 67.11 | 65.23 | 59.74 | |
| Profit Margin | -182.74 | -166.97 | -93.85 | -31.65 | -85.89 | -102.98 | -145.61 | -85.02 | |
| Operating Margin | -173.66 | -153.71 | -102.54 | -38.42 | -88.92 | -110.00 | -121.10 | -99.75 | |
|
EPS Growth
|
- - | -81.54 | -137.29 | 73.21 | -237.33 | -50.20 | -68.68 | 33.23 | |
| EPS USD | -65.00 | -118.00 | -280.00 | -75.00 | -253.00 | -380.00 | -641.00 | -428.00 | |
| Return on Assets (ROA) | -39.58 | -24.27 | -14.48 | -7.05 | -10.84 | -17.45 | -40.66 | -26.84 | |
| Return on Equity (ROE) | -57.89 | -26.97 | -17.61 | -8.50 | -18.97 | -59.65 | -1,087.72 | -302.14 | |
| Return on Invested Capital (ROIC) | -45.33 | -24.77 | -19.24 | -9.56 | -11.86 | -20.38 | -38.15 | -42.46 | |
| Solvency | |||||||||
| Equity Ratio | - - | - - | - - | - - | - - | - - | - - | - - | |
| Debt/Assets | 14.62 | 0.19 | 0.04 | 4.20 | 37.61 | 62.32 | 85.05 | 65.38 | |
| Debt/Equity | 21.38 | 0.21 | 0.05 | 5.06 | 65.81 | 212.98 | 2,275.31 | 736.00 | |
| Debt/EBITDA | 41.99 | 101.98 | 169.12 | 160.45 | -6.17 | -227.47 | -188.61 | -42.38 | |
|
Debt/Capitalization
|
17.61 | 0.21 | 0.04 | 4.82 | 39.69 | 68.05 | 95.79 | 88.04 | |
| Long-Term Debt/Capitalization | 17.50 | 0.15 | 0.02 | 4.00 | 39.50 | 67.84 | 95.72 | 87.78 | |
| Interest Debt per Share USD | 0.28 | 0.05 | 0.05 | 0.46 | 8.81 | 13.58 | 13.43 | 10.45 | |
| Debt Growth | - - | -96.13 | -67.22 | 15,296.30 | 2,449.49 | 60.51 | 0.62 | -1.13 | |
| Liquidity | |||||||||
| Current Ratio | 722.03 | 1,237.76 | 999.04 | 821.29 | 2,826.51 | 572.27 | 616.70 | 654.20 | |
| Quick Ratio | 691.63 | 1,192.78 | 968.50 | 784.76 | 2,766.36 | 529.26 | 573.69 | 610.64 | |
| Cash Ratio | 235.26 | 368.27 | 299.39 | 196.92 | 1,246.80 | 252.82 | 73.31 | 550.48 | |
| Operating Cash Flow Ratio | -200 | -300 | -100 | - - | -100 | -100 | -100 | -100 | |
| Turnover | |||||||||
| Inventory Turnover | 798.99 | 433.90 | 472.96 | 465.85 | 407.36 | 400.70 | 302.97 | 366.52 | |
| Receivables Turnover | 722.43 | 389.79 | 253.96 | 446.75 | 537.97 | 382.64 | 462.22 | 635.20 | |
| Payables Turnover | 700.79 | 632.61 | 406.03 | 436.62 | 1,260.70 | 699.16 | 88.91 | 438.82 | |
|
Asset Turnover
|
21.66 | 14.53 | 15.43 | 22.27 | 12.62 | 16.95 | 27.92 | 31.57 | |
| Fixed Turnover | 199.85 | 310.81 | 292.36 | 294.44 | 286.37 | 119.03 | 131.47 | 186.30 | |
| Coverage | |||||||||
| Interest Coverage | -1,452.85 | -2,835.38 | -7,429.42 | -6,974.68 | -5,349.35 | -15,948.82 | -21,124.49 | -21,819.82 | |
| Asset Coverage | 600 | 47,700 | 246,600 | 2,600 | 200 | 100 | 100 | 100 | |
| Cash Flow Coverage (CFGR) | -215.45 | -10,961.31 | -33,418.98 | -116.68 | -12.16 | -15.22 | -22.60 | -27.83 | |
| EBITDA Coverage | -1,300 | -2,500 | -6,600 | -5,800 | -5,000 | -14,800 | -25,200 | -20,100 | |
| Dividend Coverage | - - | - - | 2,600 | - - | - - | - - | - - | - - | |
| Time Interest Earned (TIE) | - - | - - | - - | - - | - - | - - | - - | - - | |
| Market Prospects | |||||||||
| Dividend Yield | - - | - - | 0.28 | - - | - - | - - | - - | - - | |
| Earnings Yield | -2.03 | -3.66 | -7.44 | -0.96 | -1.96 | -3.80 | -23.55 | -15.83 | |
|
Price/Earnings (P/E)
|
-4,935.21 | -2,736.15 | -1,343.53 | -10,433.52 | -5,102.39 | -2,633.63 | -424.58 | -631.82 | |
| Price/Earnings Growth (PEG) | - - | -33.56 | -9.79 | 142.51 | -21.50 | -52.47 | -6.18 | 19.01 | |
|
Price/Book (P/B)
|
2,857.18 | 737.85 | 236.54 | 886.69 | 967.76 | 1,571.06 | 4,618.21 | 1,909.00 | |
| Price/Tangible Book (P/TB) | 2,857.18 | 737.85 | 236.54 | 886.69 | 967.76 | 1,571.06 | 4,618.21 | 1,909.00 | |
| Price/Sales (P/S) | 9,018.40 | 4,568.55 | 1,260.88 | 3,302.27 | 4,382.63 | 2,711.99 | 618.24 | 537.16 | |
|
Price/Cash Flow (P/CF)
|
-6,202.82 | -3,152.29 | -1,583.22 | -15,019.41 | -12,091.48 | -4,848.13 | -898.09 | -932.16 | |
| Price/Free CF (P/FCF) | -5,918.12 | -2,803.63 | -1,237.01 | -10,346.91 | -7,954.07 | -3,567.45 | -718.29 | -876.88 | |
| Price/Operating CF (P/OCF) | -6,202.82 | -3,152.29 | -1,583.22 | -15,019.41 | -12,091.48 | -4,848.13 | -898.09 | -932.16 |